Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes

BACKGROUND: The objective of study was to determine the effect of anthracycline dose reduction and chemotherapy delays on 5-year overall survival in patients with stage I-III breast cancer, to establish the impact of molecular subtypes on the anthracycline modification effects and to analyze reasons...

Descripción completa

Detalles Bibliográficos
Autores principales: Liutkauskiene, Sigita, Grizas, Saulius, Jureniene, Kristina, Suipyte, Jorune, Statnickaite, Akvile, Juozaityte, Elona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910571/
https://www.ncbi.nlm.nih.gov/pubmed/29678165
http://dx.doi.org/10.1186/s12885-018-4365-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910571/
https://www.ncbi.nlm.nih.gov/pubmed/29678165
http://dx.doi.org/10.1186/s12885-018-4365-y

Ejemplares similares